Stockscreener 앱 받기
332.03
2.21%
7.19
시간 외 거래:
333.30
1.27
+0.38%
전일 마감가:
$324.84
열려 있는:
$325
하루 거래량:
1.21M
Relative Volume:
0.85
시가총액:
$47.86B
수익:
$2.50B
순이익/손실:
$-226.32M
주가수익비율:
-202.31
EPS:
-1.6412
순현금흐름:
$71.51M
1주 성능:
+7.13%
1개월 성능:
+24.27%
6개월 성능:
+56.53%
1년 성능:
+105.02%
1일 변동 폭
$320.41
$332.98
1주일 범위
$308.40
$333.56
52주 변동 폭
$157.43
$333.56
Natera Inc Stock (NTRA) Company Profile
명칭
Natera Inc
전화
650-249-9090
주소
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, A, IDXX
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
332.03 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
TMO
Thermo Fisher Scientific Inc
|
629.27 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
218.85 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
A
Agilent Technologies Inc
|
159.00 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
IDXX
Idexx Laboratories Inc
|
556.93 | 43.00B | 4.45B | 1.10B | 1.06B | 13.59 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-14 | 개시 | William Blair | Outperform |
| 2026-01-07 | 개시 | Citigroup | Buy |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-10-27 | 업그레이드 | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | 재개 | Wells Fargo | Equal Weight |
| 2025-03-13 | 개시 | RBC Capital Mkts | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-08 | 재개 | Craig Hallum | Buy |
| 2024-02-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-11-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2022-03-08 | 개시 | Goldman | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-09-28 | 개시 | Morgan Stanley | Overweight |
| 2020-09-17 | 개시 | SVB Leerink | Outperform |
| 2020-06-10 | 재개 | Piper Sandler | Overweight |
| 2020-05-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 개시 | JP Morgan | Neutral |
| 2018-07-05 | 재확인 | Piper Jaffray | Overweight |
| 2017-08-07 | 재확인 | Morgan Stanley | Overweight |
| 2016-11-10 | 재확인 | The Benchmark Company | Buy |
| 2016-05-23 | 재확인 | The Benchmark Company | Buy |
| 2016-05-11 | 재확인 | The Benchmark Company | Buy |
| 2016-04-19 | 개시 | The Benchmark Company | Buy |
| 2015-09-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2015-08-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 개시 | Robert W. Baird | Outperform |
| 2015-07-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 개시 | Piper Jaffray | Overweight |
| 2015-07-27 | 개시 | Wedbush | Neutral |
모두보기
Natera Inc 주식(NTRA)의 최신 뉴스
Natera’s Oncology Push Has Wall Street Paying Up - Finimize
Natera Inc. Earnings Call Highlights Rapid Growth - TipRanks
Natera raises FY26 guidance to $2.85B-$2.91B after record Q2 volume - scanx.trade
Silvant Capital Management LLC Takes $12.32 Million Position in Natera, Inc. $NTRA - MarketBeat
Virtus Advisers LLC Takes $1.01 Million Position in Natera, Inc. $NTRA - MarketBeat
Ninepoint Partners LP Purchases New Position in Natera, Inc. $NTRA - MarketBeat
D L Carlson Investment Group Inc. Makes New $3.49 Million Investment in Natera, Inc. $NTRA - MarketBeat
Deutsche Bank AG Purchases Shares of 320,037 Natera, Inc. $NTRA - MarketBeat
Danske Bank A S Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Natera (NTRA) Earnings Snapshot: Profit Per Share Surpasses Its Benchmark; Price Reaction: The Stock Loses 0.07% at the CloseEPS Guidance Update - vinanet.vn
Billionaire Stanley Druckenmiller's Top Holding Is Up 37% This Year. Is the Market Pricing in the Full Story? - AOL.com
Natera stock reaches all-time high at 326.26 USD By Investing.com - Investing.com Australia
Natera (NASDAQ:NTRA) Reaches New 1-Year HighTime to Buy? - MarketBeat
Natera stock reaches all-time high at 326.26 USD - Investing.com
Natera (NTRA) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison at the Close; Latest Reaction - vinanet.vn
Mitsubishi UFJ Asset Management Co. Ltd. Takes $50.42 Million Position in Natera, Inc. $NTRA - MarketBeat
Edmond DE Rothschild Holding S.A. Takes Position in Natera, Inc. $NTRA - MarketBeat
Eagle Health Investments LP Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Natera: Even 30% Annual Growth Through 2030 Doesn't Support $310 Per Share (NASDAQ:NTRA) - Seeking Alpha
Natera (NTRA) Quarterly Results: Profit Per Share Surpasses Its Benchmark on the Day - vinanet.vn
Is Natera Inc (NTRA) Overvalued After 4.3% Rally? GF Value Says - GuruFocus
BlackRock Inc. Buys Shares of 10,914,608 Natera, Inc. $NTRA - MarketBeat
Here's How Much $1000 Invested In Natera 10 Years Ago Would Be Worth Today - Benzinga
Q2 Rundown: Natera (NASDAQ:NTRA) Vs Other Biotechnology Stocks - Yahoo Finance
Meeder Asset Management Inc. Takes Position in Natera, Inc. $NTRA - MarketBeat
Pallas Capital Advisors LLC Buys Shares of 9,853 Natera, Inc. $NTRA - MarketBeat
How Investors May Respond To Natera (NTRA) Deepening Its MRD Role In Immunotherapy And Cancer Care - simplywall.st
K.J. Harrison & Partners Inc Buys Shares of 18,850 Natera, Inc. $NTRA - MarketBeat
Natera Inc. (NTRA) Holds Near $313 as Resistance Test LoomsMarket Neutral Pair - Vinanet
Jefferies Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $330 - Moomoo
Natera Supports Kupando Trial to Advance ctDNA Monitoring in Cancer - Yahoo Finance
NTRA Looks 42.4% Overvalued on GF Value™ - GuruFocus
Weekly Recap: FIND-CRC progress and analyst price target increases - TradingView
Natera, Inc. (NTRA) Stock Analysis: Navigating the Diagnostics Leader’s 6.68% Potential Upside - DirectorsTalk Interviews
Abbot Financial Management Inc. Takes Position in Natera, Inc. $NTRA - MarketBeat
Empowered Funds LLC Sells 9,708 Shares of Natera, Inc. $NTRA - MarketBeat
Natera director Jonathan Sheena sells $2.89m in stock By Investing.com - Investing.com Canada
Natera executive chairman Matthew Rabinowitz sells $641,800 stock By Investing.com - Investing.com Australia
Natera executive chairman Matthew Rabinowitz sells $641,800 stock - Investing.com
Net debt of Natera, Inc. – HAM:45E - TradingView
Natera director Jonathan Sheena sells $2.89m in stock - Investing.com
Natera (NTRA) Stock May Be 49% Undervalued As Guidance Rises - Yahoo Finance
Leeward Financial Partners LLC Invests $5.31 Million in Natera, Inc. $NTRA - MarketBeat
Natera (NTRA) Lands Kupando Trial Deal, Is The Upside Already Priced In? - simplywall.st
GSA Capital Partners LLP Invests $3.08 Million in Natera, Inc. $NTRA - MarketBeat
7,701 Shares in Natera, Inc. $NTRA Bought by Focus Partners Advisor Solutions LLC - MarketBeat
Natera (NTRA) Lands New Trial Collaboration But Is The Valuation Already Priced In - Yahoo Finance
Natera co-founder, Director Sheena Jonathan sells 6,000 shares worth $1.95 million - Bitget
Natera Spotlights Record Signatera Volumes, Raises Outlook at Canaccord Conference - MarketBeat
NTRA Q2 2026 Earnings: Narrower Loss Beats Estimates Despite Soft Share ReactionGeographic Revenue Trends - vinanet.vn
Natera Inc (NTRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.73%
자본화:
|
볼륨(24시간):